In agreement with our findings, no clinical evidence exists so far supporting any associations between RHC or genetic variations of MC1R and the susceptibility to nephrotic syndrome, proteinuria or glomerulopathies. This evidence concerns the gene MC1R and lipoprotein glomerulopathy.